PATENT CLAIM ANALYSIS

Application Number: 16196185
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-04
Patent Classification: ["424", "474000"]

Abstract:
The present invention relates to pharmaceutical compositions suitable for oral administration, and more particularly to pharmaceutical compositions, including pharmaceutical tablet compositions, containing N-(2-{2-dimethylaminoethyl-methylamino}-4-methoxy-5-{[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino}phenyl)prop-2-enamide (“AZD9291”) or a pharmaceutically acceptable salt thereof, wherein such compositions comprise a certain amount of microcrystalline cellulose and at least one other pharmaceutical diluent.

Claim (Index 2):
The pharmaceutical composition according to  claim 1  wherein the pharmaceutical composition comprises from 0.5 to 3 parts of the one or more pharmaceutical lubricants (e).

Metadata:
- Claim Count in Document: 30.0
- Percentile: 98.0
- Lexical Diversity: 1.31579
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15109170', '14290494', '13559805', '13578596', '15183088']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7366594633746776
- 35 USC 102 Novelty (BERT): 0.5850349102572693
- Combined Prediction Score: 0.7214970080629368
- Mean Citation Score: 273.471976
- Max Citation Score: 492.75302
- Similarity Product: 431.447162668978

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test